Cas No.: | 1378266-98-8 |
Chemical Name: | (S)-5-chloro-N-((2-oxo-3-(4-(2-oxopyridin-1(2H)-yl)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
SMILES: | C(C(NC[C@H]1OC(=O)N(C2=CC=C(N3C(=O)C=CC=C3)C=C2)C1)=O)1SC(Cl)=CC=1 |
Formula: | C20H16ClN3O4S |
M.Wt: | 429.875 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Zifaxaban is a novel, potent, selective, direct and oral factor Xa inhibitor with IC50 of 11.1 nM (human FXa), displays > 10,000-fold selectivity than other serine proteases; also deoes not impair platelet aggregation induced by collagen, adenosine diphosphate (ADP) or arachidonic acid; significantly prolongs clotting time, prothrombin time (PT), and activated partial thromboplastin time (APTT) in the plasma of humans, rabbits, and rats, with a relatively weak effect on thrombin time; strongly suppresses thrombus formation with ED50 values of 3.09 mg/kg in venous thrombosis models in rats. |